Literature DB >> 3540594

Coinfection with viruses carrying the v-Ha-ras and v-myc oncogenes leads to growth factor independence by an indirect mechanism.

M Vogt, J Lesley, J Bogenberger, S Volkman, M Haas.   

Abstract

The concomitant expression of certain oncogenes can transform normal diploid rodent cells into transplantable tumorigenic cells. The mechanism by which these oncogenes collaborate is unclear. Recent findings (M. Oshimura, T. M. Gilmer, and J. C. Barrett, Nature [London] 316:636-639, 1985) raise the possibility that karyotypic changes, including monosomy for chromosome 15, are required to induce tumorigenicity in Syrian hamster embryo cells transfected in vitro with v-Ha-ras and v-myc DNAs. We studied the effect of the oncogenes v-Ha-ras and v-myc, introduced by viral infection, on murine hematopoietic cells. The induction of growth factor independence by the two oncogenes was used as an in vitro correlate of tumorigenicity. After a period of reduced growth rate reminiscent of the growth rate of cells in crisis, the doubly infected cells became growth factor independent. These cells showed a great variability in their karyotypes.

Entities:  

Mesh:

Year:  1986        PMID: 3540594      PMCID: PMC367105          DOI: 10.1128/mcb.6.10.3545-3549.1986

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  14 in total

1.  Comparison of the expression of the src gene of Rous sarcoma virus in vitro and in vivo.

Authors:  B M Sefton; K Beemon; T Hunter
Journal:  J Virol       Date:  1978-12       Impact factor: 5.103

2.  Suppression of tumorigenicity in hybrids of normal and oncogene-transformed CHEF cells.

Authors:  R W Craig; R Sager
Journal:  Proc Natl Acad Sci U S A       Date:  1985-04       Impact factor: 11.205

3.  Suppression of malignancy by cell fusion.

Authors:  H Harris; O J Miller; G Klein; P Worst; T Tachibana
Journal:  Nature       Date:  1969-07-26       Impact factor: 49.962

4.  Colony formation in vitro by myelomonocytic leukemic cells.

Authors:  D Metcalf; M A Moore; N L Warner
Journal:  J Natl Cancer Inst       Date:  1969-10       Impact factor: 13.506

5.  DNAase I encapsulated in liposomes can induce neoplastic transformation of Syrian hamster embryo cells in culture.

Authors:  M Zajac-Kaye; P O Ts'o
Journal:  Cell       Date:  1984-12       Impact factor: 41.582

6.  Specific chromosome loss associated with the expression of tumorigenicity in human cell hybrids.

Authors:  E J Stanbridge; R R Flandermeyer; D W Daniels; W A Nelson-Rees
Journal:  Somatic Cell Genet       Date:  1981-11

7.  Augmented expression of normal c-myc is sufficient for cotransformation of rat embryo cells with a mutant ras gene.

Authors:  W M Lee; M Schwab; D Westaway; H E Varmus
Journal:  Mol Cell Biol       Date:  1985-12       Impact factor: 4.272

8.  Monoclonal antibodies to the p21 products of the transforming gene of Harvey murine sarcoma virus and of the cellular ras gene family.

Authors:  M E Furth; L J Davis; B Fleurdelys; E M Scolnick
Journal:  J Virol       Date:  1982-07       Impact factor: 5.103

9.  Nonrandom loss of chromosome 15 in Syrian hamster tumours induced by v-Ha-ras plus v-myc oncogenes.

Authors:  M Oshimura; T M Gilmer; J C Barrett
Journal:  Nature       Date:  1985 Aug 15-21       Impact factor: 49.962

10.  Viral and cellular fos proteins are complexed with a 39,000-dalton cellular protein.

Authors:  T Curran; C Van Beveren; I M Verma
Journal:  Mol Cell Biol       Date:  1985-01       Impact factor: 4.272

View more
  14 in total

1.  bcr/abl and src but not myc and ras replace v-abl in lymphoid transformation.

Authors:  A Engelman; N Rosenberg
Journal:  Mol Cell Biol       Date:  1990-08       Impact factor: 4.272

2.  Cooperative transforming activities of ras, myc, and src viral oncogenes in nonestablished rat adrenocortical cells.

Authors:  A MacAuley; T Pawson
Journal:  J Virol       Date:  1988-12       Impact factor: 5.103

3.  Oncogene cooperation in lymphocyte transformation: malignant conversion of E mu-myc transgenic pre-B cells in vitro is enhanced by v-H-ras or v-raf but not v-abl.

Authors:  W S Alexander; J M Adams; S Cory
Journal:  Mol Cell Biol       Date:  1989-01       Impact factor: 4.272

Review 4.  Suppression of the neoplastic phenotype and "anti-oncogenes".

Authors:  R Schäfer
Journal:  Blut       Date:  1987-05

5.  Nature and specificity of lymphokine independence induced by a selectable retroviral vector expressing v-src.

Authors:  R W Overell; J D Watson; B Gallis; K E Weisser; D Cosman; M B Widmer
Journal:  Mol Cell Biol       Date:  1987-10       Impact factor: 4.272

6.  Retention or loss of v-mil sequences after propagation of MH2 virus in vivo or in vitro.

Authors:  B Biegalke; M Linial
Journal:  J Virol       Date:  1987-06       Impact factor: 5.103

7.  Tyrosine kinase oncogenes abrogate interleukin-3 dependence of murine myeloid cells through signaling pathways involving c-myc: conditional regulation of c-myc transcription by temperature-sensitive v-abl.

Authors:  J L Cleveland; M Dean; N Rosenberg; J Y Wang; U R Rapp
Journal:  Mol Cell Biol       Date:  1989-12       Impact factor: 4.272

8.  The VBP and a1/EBP leucine zipper factors bind overlapping subsets of avian retroviral long terminal repeat CCAAT/enhancer elements.

Authors:  C D Smith; L A Baglia; S M Curristin; A Ruddell
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

9.  a1/EBP: a leucine zipper protein that binds CCAAT/enhancer elements in the avian leukosis virus long terminal repeat enhancer.

Authors:  W J Bowers; A Ruddell
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

10.  A v-H-ras-dependent hemopoietic tumor model involving progression from a clonal stage of transformation competence to autocrine interleukin 3 production.

Authors:  A P Nair; I D Diamantis; J F Conscience; V Kindler; P Hofer; C Moroni
Journal:  Mol Cell Biol       Date:  1989-03       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.